Netherlands· NL-e5c9f230768f
Tracrium 10 mg/ml oplossing voor injectie/infusie
A atracurium product containing atracuriumdibesilaat, registered in Netherlands by Aspen Pharma Trading Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Atracurium is registered in 13 of 19 countries.
Countries holding a registration under ATC M03AC04 (atracurium), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Atracurium · ATC M03AC04
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ATRACURIUMDIBESILAAT
- Manufacturer
- Aspen Pharma Trading Limited
- Country
- Netherlands (NL)
- ATC code
- M03AC04
- ATC class
- Atracurium
- Defined daily dose
- 38.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id09981
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
60 interactions on record for atracurium.
Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atracurium · interactions on record
60 records
- 12 severe
- 44 moderate
- 4 minor
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- ParomomycinA07AA06severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Atracurium in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAtracurium Labatec 10 mg/ml, solution injectable / pour perfusionLabatec Pharma SA
- SpainBESILATO DE ATRACURIO KALCEKS 10 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFGKalceks As
- PolandAtracurium KalceksDelfarma Sp. z o.o.
- United KingdomAtracurium besilate 10mg/5ml solution for injection vialsSpecial Order
- FranceATRACURIUM HIKMA 10 mg/mL, solution injectable/pour perfusionHIKMA FARMACEUTICA (PORTUGAL)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1856f2f8-3191-45d5-8a52-17ecd2e8f606 GET /v1/drugs/1856f2f8-3191-45d5-8a52-17ecd2e8f606?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie of infusie",
"route": null,
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h09981_smpc.pdf",
"strength": null,
"atc_label": "Atracurium",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg09981",
"excipients": [
"BENZEENSULFONZUUR",
"WATER VOOR INJECTIE"
],
"substances": [
"ATRACURIUMDIBESILAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h09981.pdf",
"authorised_at": "1984/11/08",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "09981",
"additional_monitoring": "N"
}See everything about atracurium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.